Kaiser Permanente Ventures is among the investors in an AI startup focused on medication management.
The venture capital arm of the Oakland, Calif.-based health system participated in a $30 million series C funding round June 24 for Arine. The company plans to use the funding to expand into specialty pharmacy management and advance AI automation, according to a news release.
Arine supports health plans and risk-bearing providers with a medication optimization platform for value-based care. Venture capital firm Town Hall Ventures led the funding round.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.